Acxiom (ACXM) was upgraded to outperform at BMO Capital. $28 price target. Earnings estimates were also increased, given a better growth outlook and higher stock buybacks, BMO said.
Newfield (NFX) was downgraded to equal-weight from overweight at Barclays. The valuation is less attractive, based on a $44 price target.